oxae 50 mikrogram/dosis næsespray, suspension
laboratoires gerda - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis
parilo 50 mikrogram/dosis næsespray, suspension
laboratoires gerda - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis
prausin 50 mikrogram/dosis næsespray, suspension
eg labo - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis
metmin 50 mikrogram/dosis næsespray, suspension
adamed sp. z.o.o. - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis
rinoter 50 mikrogram/dosis næsespray, suspension
farma group srl - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis
elocon 1 mg/g creme
orifarm a/s - mometasonfuroat - creme - 1 mg/g
elocon 1 mg/g salve
orifarm a/s - mometasonfuroat - salve - 1 mg/g
elocon 0,1 % kutanopløsning
orifarm a/s - mometasonfuroat - kutanopløsning - 0,1 %
monovo 1 mg/g kutanemulsion
almirall hermal gmbh - mometasonfuroat - kutanemulsion - 1 mg/g
atectura breezhaler
novartis europharm limited - indacaterol acetate, mometasone furoate - astma - medicin for obstruktiv sygdomme, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.